![Frontiers | Advances in Drug Resistance of Esophageal Cancer: From the Perspective of Tumor Microenvironment Frontiers | Advances in Drug Resistance of Esophageal Cancer: From the Perspective of Tumor Microenvironment](https://www.frontiersin.org/files/MyHome%20Article%20Library/664816/664816_Thumb_400.jpg)
Frontiers | Advances in Drug Resistance of Esophageal Cancer: From the Perspective of Tumor Microenvironment
![Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics | Nature Communications Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-018-05190-9/MediaObjects/41467_2018_5190_Fig1_HTML.png)
Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics | Nature Communications
![Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment | Nature Communications Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-020-20019-0/MediaObjects/41467_2020_20019_Fig1_HTML.png)
Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment | Nature Communications
![Esophageal motion characteristics in thoracic esophageal cancer: Impact of clinical stage T4 versus stages T1-T3 - Advances in Radiation Oncology Esophageal motion characteristics in thoracic esophageal cancer: Impact of clinical stage T4 versus stages T1-T3 - Advances in Radiation Oncology](https://www.advancesradonc.com/cms/attachment/4dda28a9-98d2-4240-8540-fd4860ff83e9/gr1.jpg)
Esophageal motion characteristics in thoracic esophageal cancer: Impact of clinical stage T4 versus stages T1-T3 - Advances in Radiation Oncology
![Tumor-associated autoantibodies in ESCC screening: Detecting prevalent early-stage malignancy or predicting future cancer risk? - eBioMedicine Tumor-associated autoantibodies in ESCC screening: Detecting prevalent early-stage malignancy or predicting future cancer risk? - eBioMedicine](https://www.thelancet.com/cms/attachment/1627be14-a160-49b1-87a4-c9d7e0061887/gr1_lrg.jpg)
Tumor-associated autoantibodies in ESCC screening: Detecting prevalent early-stage malignancy or predicting future cancer risk? - eBioMedicine
![Cancers | Free Full-Text | The Distinctive Serum Metabolomes of Gastric, Esophageal and Colorectal Cancers Cancers | Free Full-Text | The Distinctive Serum Metabolomes of Gastric, Esophageal and Colorectal Cancers](https://www.mdpi.com/cancers/cancers-13-00720/article_deploy/html/images/cancers-13-00720-g001.png)
Cancers | Free Full-Text | The Distinctive Serum Metabolomes of Gastric, Esophageal and Colorectal Cancers
![Current advances in prognostic and diagnostic biomarkers for solid cancers: Detection techniques and future challenges - ScienceDirect Current advances in prognostic and diagnostic biomarkers for solid cancers: Detection techniques and future challenges - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332221012749-gr2.jpg)
Current advances in prognostic and diagnostic biomarkers for solid cancers: Detection techniques and future challenges - ScienceDirect
![Fat density is a novel prognostic marker in patients with esophageal cancer - Clinical Nutrition ESPEN Fat density is a novel prognostic marker in patients with esophageal cancer - Clinical Nutrition ESPEN](https://clinicalnutritionespen.com/cms/attachment/a22980b0-4c92-42da-9448-c4d357d2c45a/gr1_lrg.jpg)
Fat density is a novel prognostic marker in patients with esophageal cancer - Clinical Nutrition ESPEN
![Cells | Free Full-Text | Linking Cancer Stem Cell Plasticity to Therapeutic Resistance-Mechanism and Novel Therapeutic Strategies in Esophageal Cancer Cells | Free Full-Text | Linking Cancer Stem Cell Plasticity to Therapeutic Resistance-Mechanism and Novel Therapeutic Strategies in Esophageal Cancer](https://www.mdpi.com/cells/cells-09-01481/article_deploy/html/images/cells-09-01481-g001.png)
Cells | Free Full-Text | Linking Cancer Stem Cell Plasticity to Therapeutic Resistance-Mechanism and Novel Therapeutic Strategies in Esophageal Cancer
![CA19-9-producing esophageal adenocarcinoma originating from the esophageal cardia of the mid-thoracic esophagus: a case report | Surgical Case Reports | Full Text CA19-9-producing esophageal adenocarcinoma originating from the esophageal cardia of the mid-thoracic esophagus: a case report | Surgical Case Reports | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40792-021-01252-1/MediaObjects/40792_2021_1252_Fig1_HTML.jpg)
CA19-9-producing esophageal adenocarcinoma originating from the esophageal cardia of the mid-thoracic esophagus: a case report | Surgical Case Reports | Full Text
![Cancers | Free Full-Text | Identification of Cancer Stem Cell Molecular Markers and Effects of hsa-miR-21-3p on Stemness in Esophageal Squamous Cell Carcinoma Cancers | Free Full-Text | Identification of Cancer Stem Cell Molecular Markers and Effects of hsa-miR-21-3p on Stemness in Esophageal Squamous Cell Carcinoma](https://www.mdpi.com/cancers/cancers-11-00518/article_deploy/html/images/cancers-11-00518-g001.png)
Cancers | Free Full-Text | Identification of Cancer Stem Cell Molecular Markers and Effects of hsa-miR-21-3p on Stemness in Esophageal Squamous Cell Carcinoma
![IJMS | Free Full-Text | Biomarkers for Early Detection, Prognosis, and Therapeutics of Esophageal Cancers IJMS | Free Full-Text | Biomarkers for Early Detection, Prognosis, and Therapeutics of Esophageal Cancers](https://www.mdpi.com/ijms/ijms-24-03316/article_deploy/html/images/ijms-24-03316-g001.png)
IJMS | Free Full-Text | Biomarkers for Early Detection, Prognosis, and Therapeutics of Esophageal Cancers
![Frontiers | Diagnostic, Prognostic, and Recurrence Monitoring Value of Plasma CYFRA21-1 and NSE Levels in Patients With Esophageal Squamous Cell Carcinoma Frontiers | Diagnostic, Prognostic, and Recurrence Monitoring Value of Plasma CYFRA21-1 and NSE Levels in Patients With Esophageal Squamous Cell Carcinoma](https://www.frontiersin.org/files/Articles/789312/fonc-11-789312-HTML/image_m/fonc-11-789312-g001.jpg)